The FDA’s Oncologic Drugs Advisory Committee will discuss the use of immune checkpoint inhibitors in patients with stomach and esophageal cancers, potentially limiting their use for those with low PD-L1 expression due to lack of benefits and possible risks.
Researchers have developed a new AI-powered test that can potentially diagnose three major types of cancer using only a single spot of dried blood. The test, which analyzes metabolites in blood samples, showed high accuracy in preliminary experiments, detecting cancer in 82% to 100% of cases. The tool could revolutionize cancer screening by providing a low-cost, accessible method for early detection. However, further testing and validation are needed before the test can be used in clinical practice.
